Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical (NASDAQ: ISRG) will report its Q2 2024 results on Thursday, July 18. We expect the company's revenues to come in at $2 billion and adjusted earnings to be $1.55 per share, broadly aligning with the consensus estimate.

Da Vinci 5 In Focus As Intuitive Surgical Reports Its Q2

The Intuitive Surgical (NASDAQ: ISRG) stock price is hovering near its all-time highest point on record as investors focus on its upcoming quarterly earnings. It has soared by 30% this year and by over 735% in the past decade, making it one of the most successful medical device companies in Wall Street.

Intuitive Surgical: ISRG stock is expensive and extremely risky

Intuitive Surgical's (ISRG) second-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs might have hurt margins.

How to Play Intuitive Surgical (ISRG) Ahead of Q2 Earnings?

Alcon Inc. - Registered Shares

DexCom

Hologic

Thermo Fisher Scientific

DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific are included in this Analyst Blog.

The Zacks Analyst Blog DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific

Intuitive Surgical's revenue and EPS for Q1 beat estimates, and the stock has risen 17% since the last earnings preview. The release of the da Vinci 5 robotic system is expected to boost sales by encouraging upgrades among current users. Analysts expect Q2 EPS of $1.54 and revenue of $1.97 billion, with a focus on procedure growth and new system placements.

Intuitive Surgical Q2 Earnings Preview: Near-Term Volatility, Long-Term Growth

We have narrowed our search to five Medical Instruments stocks. These are: DXCM, TMO, ISRG, ALC, HOLX.

Buy 5 Medical Devices Stocks to Enhance Your Portfolio in 2H

Veeva Systems

These two stellar companies have performed even better than that in the past 10 years. Both are leaders in their respective niches, with strong moats and solid growth prospects.

2 Top Growth Stocks That Could Turn $1,000 Into $4,000 in 10 Years

Agilent Technologies

UnitedHealth Group

Intuitive Surgical's game-changing robotic surgical systems should continue fueling considerable growth for the business. UnitedHealth is in an excellent position to benefit from the health insurance industry's long-term growth.

History Says These Could Be 3 of the Best Healthcare Stocks to Own in the Second Half of 2024

ISRG has been outperforming medical device stocks and S&P 500 amid strong earnings growth and technical momentum. More EPS gains are expected over the coming quarters, but the valuation has become a concern. ISRG showing strong technical momentum, with shares breaking out above key resistance.

Intuitive Surgical: Shares Surge, But Now Near Fair Value (Rating Downgrade)

Abbott Labs

AstraZeneca

Merck

PACS Group, Inc.

Pfizer

Tenet Healthcare

In my view, it's important for every individual to invest in equities. By just holding cash in a back account, there is bound to be loss of purchasing power when adjusted for inflation.

7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns

Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $442.30, moving -0.5% from the previous trading session.

Intuitive Surgical, Inc. (ISRG) Stock Slides as Market Rises: Facts to Know Before You Trade

Apple

Amazon

Booking Hlds

Netflix

NVIDIA

The 10 best performing stocks over the past two decades share several similar attributes. Investors should study and understand the common traits of true market leaders.

Investing Lessons: The 10 Best Stocks of the Past 20 Years

Pegasystems

SoundHound AI Inc

AI stocks are still in the spotlight in the constantly changing financial landscape. They present investors with bright future possibilities through 2024 and beyond.

3 Hidden AI Gems That Could Outshine the Giants

Monster Beverage

We believe that the beverage company – Monster Beverage (NASDAQ: MNST) is currently a better pick over the robotic surgical platform maker Intuitive Surgical stock (NASDAQ: ISRG). The decision to invest often comes down to finding the best stocks within the scope of certain characteristics that suit an investment style.

After A 15% Fall This Year Is Monster Beverage A Better Pick Over Intuitive Surgical Stock?

Serve Robotics Inc

Tesla

The growth of artificial intelligence is a rising tide that raises all ships. This is evident when looking at one-year growth of companies such as Microsoft (NASDAQ: MSFT ), Meta Platforms (NASDAQ: META ) and Nvidia (NASDAQ: NVDA ), through a historic AI bull run that we are still in.

The 3 Smartest Robotics Stocks to Buy With $500 Right Now

Intuitive Surgical (ISRG) is making strides in the robotic-assisted surgery market with its existing and new launches. However, macro challenges are likely to continue to hurt its performance.

Intuitive Surgical (ISRG) Rises 10% in a Month: What's Next?

Creo Medical Group PLC (AIM:CREO) and Intuitive Surgical Inc (NASDAQ:ISRG, ETR:IUI1) have expanded their collaboration to enhance lung cancer treatments across the UK and Europe. This initiative broadens the scope of an agreement that combines diagnostics and treatment in a single procedure using advanced medical technology.

Creo Medical accelerates collaboration with US robotic surgery group

iRobot

Symbotic Inc

There are multiple signs that robots are already being used on a very wide scale and will soon proliferate throughout society. For example, Tesla (NASDAQ: TSLA ) recently reported that it had begun successfully using two of its humanoid, artificial intelligence-powered autonomous robots in one of its factories.

The 3 Best Robotics Stocks to Buy in July 2024

Eli Lilly

These profitable businesses are leaders in their respective healthcare sectors. Intuitive Surgical is the global market leader in surgical robotics, with a sneaky recurring revenue model.

2 Top Healthcare Stocks to Buy in June

Intuitive Surgical is capturing strong demand for its lineup of robotic surgical systems. Analysts anticipate new artificial intelligence and machine learning features to drive growth.

Intuitive Surgical Stock: Buy, Sell, or Hold?

The latest trading day saw Intuitive Surgical, Inc. (ISRG) settling at $442.56, representing a +0.06% change from its previous close.

Intuitive Surgical, Inc. (ISRG) Rises But Trails Market: What Investors Should Know

Investors are optimistic about Intuitive Surgical's (ISRG) strength in robotics.

Intuitive Surgical (ISRG) Hits 52-Week High: What's Aiding It?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Wall Street Bulls Look Optimistic About Intuitive Surgical (ISRG): Should You Buy?

Baidu

Alphabet

Confession Time: I Own 5 Industry-Leading Artificial Intelligence (AI) Stocks, but Not for the Reason You Might Think

Transmedics Group Inc

United Therapeutics

Medical devices are spearheading the digitalization of healthcare, reports analytics and software development company Luxoft. Specifically, medical devices are “providing accurate diagnoses, effective treatments and personalized care through advanced algorithms and patient data analysis.

News for Intuitive Surgical Stock (ISRG)